nach oben

Current Urology Reports

Erschienen in:

01.11.2010

Overactive Bladder and Pain: Management Strategies

verfasst von: Bhavin N. Patel, Robert J. Evans

Erschienen in: Current Urology Reports | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Overactive bladder associated with pain (ie, interstitial cystitis/bladder pain syndrome [IC/BPS]) is a prevalent condition that can be very difficult to diagnose and even more difficult to treat. In this paper, we review the studied therapies for IC/BPS, including non–medication-based therapies, oral and intravesical-based medications, and surgical treatments for interstitial cystitis. We also review an approach to the treatment of a patient with IC/BPS using the previously published UPOINT clinical phenotyping template.

• Hanno P, Dmochowski R: Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 2009, 28:274–286. This is an article of importance because it outlines the inherent difficulties in defining and naming a condition that is broad in its symptomatology . CrossRefPubMed

Whitmore KE: Self-care regimens for patients with interstitial cystitis. Urol Clin North Am 1994, 21:121–130.PubMed

Whitmore KE: Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol 2002, 4(Suppl 1):S28–S35.PubMed

• Foster HE Jr, Hanno PM, Nickel JC, et al.: Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. J Urol 2010, 183:1853–1858. This study shows the importance of standardized education and behavioral modification in patients with IC/BPS.CrossRefPubMed

• FitzGerald MP, Anderson RU, Potts J, et al.: Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2009, 182:570–580. This is an important study demonstrating the relative effectiveness of myofascial physical therapy compared to therapeutic message in relieving symptoms of IC/BPS.CrossRefPubMed

Rapkin AJ, Kames LD: The pain management approach to chronic pelvic pain. J Reprod Med 1987, 32:323–327.PubMed

Geirsson G, Wang YH, Lindström S, Fall M: Traditional acupuncture and electrical stimulation of the posterior tibial nerve. A trial in chronic interstitial cystitis. Scand J Urol Nephrol 1993, 27:67–70.

Mulholland SG, Hanno P, Parsons CL, et al.: Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 1990, 35:552–558.

Parsons CL, Benson G, Childs SJ, et al.: A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 1993, 150:845–848.PubMed

10.

Sant GR, Propert KJ, Hanno PM, et al.: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003, 170:810–815.CrossRefPubMed

11.

Holm-Bentzen M, Jacobsen F, Nerstrøm B, et al.: A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 1987, 138:503–507.PubMed

12.

Thilagarajah R, Witherow RO, Walker MM: Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 2001, 87:207–212.CrossRefPubMed

13.

Seshadri P, Emerson L, Morales A: Cimetidine in the treatment of interstitial cystitis. Urology 1994, 44:614–616.CrossRefPubMed

14.

Dasgupta P, Sharma SD, Womack C, et al.: Cimetidine in painful bladder syndrome: a histopathological study. BJU Int 2001, 88:183–186.CrossRefPubMed

15.

Minogiannis P, El-Mansoury M, Betances JA, et al.: Hydroxyzine inhibits neurogenic bladder mast cell activation. Int J Immunopharmacol 1998, 20:553–563.CrossRefPubMed

16.

Theoharides TC: Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am 1994, 21:113–119.PubMed

17.

Theoharides TC, Sant GR: Hydroxyzine therapy for interstitial cystitis. Urology 1997, 49(5A Suppl):108–110.

18.

van Ophoven A, Pokupic S, Heinecke A, Hertle L: A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004, 172:533–536.CrossRefPubMed

19.

Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004, 171:2138–2141.CrossRefPubMed

20.

Sairanen J, Tammela TL, Leppilahti M, et al.: Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2005, 174:2235–2238.CrossRefPubMed

21.

Parsons CL: Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005, 65:45–48.CrossRefPubMed

22.

• Welk BK, Teichman JM: Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology 2008, 71:67–70. This study demonstrates the positive effects of intravesical therapy on sexual function and pain in patients with IC.CrossRefPubMed

23.

Nickel JC, Moldwin R, Lee S, et al.: Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009, 103:910–918.CrossRefPubMed

24.

Parsons CL, Housley T, Schmidt JD, Lebow D: Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994, 73:504–507.CrossRefPubMed

25.

Aihara K, Hirayama A, Tanaka N, et al.: Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol 2009, 16:947–952.CrossRefPubMed

26.

Ottem DP, Teichman JM: What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 2005, 66:494–499.CrossRefPubMed

27.

Peeker R, Aldenborg F, Fall M: Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 2000, 11:290–295.CrossRefPubMed

28.

Rofeim O, Hom D, Freid RM, Moldwin RM: Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol 2001, 166:134–136.CrossRefPubMed

29.

Cox M, Klutke JJ, Klutke CG: Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis. Can J Urol 2009, 16:4536–4540.PubMed

30.

• Pinto R, Lopes T, Frias B, et al.: Trigonal Injection of Botulinum Toxin A in Patients with Refractory Bladder Pain Syndrome/Interstitial Cystitis. Eur Urol 2010 Mar 6 (Epub ahead of print). This observational study documents the positive effect and the length of effect on voiding parameters of trigonal botulinum toxin in patients with IC.

31.

Gottsch HP, Miller JL, Yang CC, Berger RE: A pilot study of botulinum toxin for interstitial cystitis/painful bladder syndrome. Neurourol Urodyn 2010 Jun 29 (Epub ahead of print).

32.

Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003, 169:1369–1373.CrossRefPubMed

33.

Lotenfoe RR, Christie J, Parsons A, et al.: Absence of neuropathic pelvic pain and favorable psychological profile in the surgical selection of patients with disabling interstitial cystitis. J Urol 1995, 154:2039–2042.CrossRefPubMed

34.

•• Shoskes DA, Nickel JC, Kattan MW: Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 2010, 75:1249–1253. This is a paper of major importance because it provides a practical algorithm for the evaluation of patients with IC/BPS.CrossRefPubMed

Titel: Overactive Bladder and Pain: Management Strategies
verfasst von: Bhavin N. Patel
Robert J. Evans
Publikationsdatum: 01.11.2010
Verlag: Current Science Inc.
Erschienen in: Current Urology Reports / Ausgabe 6/2010
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-010-0141-5

Neu im Fachgebiet Urologie

18.04.2024 | Infertilität | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Overactive Bladder and Pain: Management Strategies

Abstract

Neu im Fachgebiet Urologie

Viele Ärzte haben Probleme mit der Zeugungsfähigkeit

Hochrisiko-Eingriffe für postoperative Übelkeit

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Augmentation Enterocystoplasty in Overactive Bladder: Is There Still a Role?

New Concepts in the Diagnosis and Treatment of Premature Ejaculation

Selection of Ideal Candidates for Neuromodulation in Refractory Overactive Bladder

Clinical Trials Report: Pazopanib for Advanced Renal Cell Carcinoma: Comments on the Results from the Phase 3 Study

Gene Therapy for Erectile Dysfunction: What Is the Future?

Androgen Replacement Therapy After Prostate Cancer Treatment

Neu im Fachgebiet Urologie

Viele Ärzte haben Probleme mit der Zeugungsfähigkeit

Hochrisiko-Eingriffe für postoperative Übelkeit

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Update Urologie